GlaxoSmithKline Pharmaceuticals Ltd

NSE: GLAXO · BSE: 500660 · Pharmaceuticals & Biotechnology · 34 announcements

Share price: ₹2,628.40
Market cap: ₹44,527 Cr
Revenue (annual): ₹3,822 Cr
Net profit (annual): ₹1,036 Cr
P/E (TTM): 41.7×Sector 47.4×
Promoter holding: 75.00%+0.00% QoQ
FII holding: 4.79%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Management Change 5 Annual General Meeting 5 Other Announcement 4 Financial Results 3 Results Update 2 Legal & Regulatory 2 Board Meeting Outcome 2 Price Movement Clarification 1 Dividend 1 Business Update 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

3 Aug 2026 16:07 IST NSE

Results Update

GlaxoSmithKline Pharmaceuticals Results Update

GSK India reported Q1 FY27 financial results with revenue at INR 924 crore and PAT at INR 253 crore. The company highlights growth across key therapeutic portfolios.

Read the filing ↗

13 May 2026 15:50 IST BSE

Results Update

GlaxoSmithKline Pharmaceuticals Results Update

GSK India reported full-year revenue of ₹3790 Crore and PAT of ₹1012 Crore. The board recommended a final dividend of ₹57 per equity share.

Value: ₹1,012 Cr

Read the filing ↗